mesulergine has been researched along with Dyskinesia Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dietl, MM; Hoyer, D; Palacios, JM; Waeber, C | 1 |
| Montastruc, JL; Rascol, A; Rascol, O; Senard, JM | 1 |
2 other study(ies) available for mesulergine and Dyskinesia Syndromes
| Article | Year |
|---|---|
5.HT1 receptors in the vertebrate brain. Regional distribution examined by autoradiography.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aged; Animals; Autoradiography; Brain; Cats; Disease Models, Animal; Dogs; Ergolines; Female; Guinea Pigs; Humans; Macaca mulatta; Male; Mice; Movement Disorders; Receptors, Serotonin; Serotonin; Tetrahydronaphthalenes; Tritium | 1989 |
Mesulergine (CU 32-085) in the treatment of Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Drug Administration Schedule; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors | 1986 |